Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | formyl peptide receptor 2 | Starlite/ChEMBL | References |
Homo sapiens | formyl peptide receptor 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | G-protein coupled receptor, putative | formyl peptide receptor 2 | 351 aa | 303 aa | 21.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0994 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0977 | 0.9706 | 0.9604 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0994 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0977 | 0.9706 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0994 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0586 | 0.2852 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0586 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0994 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0586 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0977 | 0.9706 | 0.9706 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0994 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0586 | 0.2852 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0586 | 0.2852 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0994 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0977 | 0.9706 | 0.9706 |
Onchocerca volvulus | 0.0994 | 1 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0994 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0977 | 0.9706 | 0.9706 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 2.1 uM | Agonist activity at FPR1/FPR2 in human neutrophils assessed as induction of Ca2+ mobilization | ChEMBL. | 23685570 |
EC50 (binding) | = 7.8 uM | Agonist activity at FPR2 (unknown origin) transfected in human HL60 cells assessed as induction of Ca2+ mobilization | ChEMBL. | 23685570 |
EC50 (binding) | = 12.8 uM | Agonist activity at FPR1 (unknown origin) transfected in human HL60 cells assessed as induction of Ca2+ mobilization | ChEMBL. | 23685570 |
EC50 (binding) | > 50 uM | Agonist activity at FPR3 (unknown origin) transfected in human HL60 cells assessed as induction of Ca2+ mobilization | ChEMBL. | 23685570 |
EC50 (functional) | > 50 uM | Effect on Ca2+ mobilization in human wild type HL60 cells | ChEMBL. | 23685570 |
Efficacy (binding) | = 100 % | Agonist activity at FPR1 (unknown origin) transfected in human HL60 cells assessed as induction of Ca2+ mobilization relative to fMLF | ChEMBL. | 23685570 |
Efficacy (binding) | = 105 % | Agonist activity at FPR1/FPR2 in human neutrophils assessed as induction of Ca2+ mobilization relative to fMLF | ChEMBL. | 23685570 |
Efficacy (binding) | = 110 % | Agonist activity at FPR2 (unknown origin) transfected in human HL60 cells assessed as induction of Ca2+ mobilization relative to WKYMVm | ChEMBL. | 23685570 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.